Search Results - "Berghoff, A.S."

2928 Laboratory parameters have independent prognostic impact in patients with newly diagnosed brain metastases: analysis of 1201 cases by Berghoff, A.S, Koller, R, Widhalm, G, Dieckmann, K, Zielinski, C.C, Birner, P, Bartsch, R, Preusser, M

Get full text

2927 Programmed death ligand 1 (PD-L1) expression and tumor infiltrating lymphocytes in diffuse and anaplastic gliomas by Berghoff, A.S, Kiesel, B, Widhalm, G, Rajky, O, Ricken, G, Wöhrer, A, Dieckmann, K, Zielinski, C.C, Marosi, C, Preusser, M

Get full text

2923 Role of endocrine therapy in breast cancer (BC) patients with brain metastases by Bergen, E, Berghoff, A.S, Rudas, M, Dubsky, P, Gnant, M, Dieckmann, K, Widhalm, G, Zielinski, C.C, Steger, G.G, Preusser, M, Bartsch, R

Get full text

2926 Tumor-infiltrating lymphocytes (TILs) and PDL1 expression in lung cancer brain metastases by Berghoff, A.S, Cansu, I, Rajky, O, Ricken, G, Widhalm, G, Dieckmann, K, Birner, P, Oberndorfer, F, Dome, B, Bartsch, R, Zielinski, C, Preusser, M

Get full text

The PERS2ON score for systemic assessment of symptomatology in palliative care: a pilot study by Masel, E.K., Berghoff, A.S., Schur, S., Maehr, B., Schrank, B., Simanek, R., Preusser, M., Marosi, C., Watzke, H.H.

“…The comprehensive assessment of symptoms is the basis for effective, individualised palliative treatment. Established scoring systems provide in‐depth…”
Get full text

EANO–ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours by Le Rhun, E., Guckenberger, M., Smits, M., Dummer, R., Bachelot, T., Sahm, F., Galldiks, N., de Azambuja, E., Berghoff, A.S., Metellus, P., Peters, S., Hong, Y.-K., Winkler, F., Schadendorf, D., van den Bent, M., Seoane, J., Stahel, R., Minniti, G., Wesseling, P., Weller, M., Preusser, M.

“…•This Clinical Practice Guideline provides management recommendations for patients with brain metastases from solid tumours.•The guideline covers clinical and…”
Get full text

830P Isolation of cell-free DNA of patients with mucosa-associated lymphoid tissue (MALT) lymphoma by Berger, J.M., Kienzle, A., Hatziioannou, T., Tomasich, E., Mayerhoefer, M., Kiesewetter-Wiederkehr, B., Berghoff, A.S., Preusser, M., Raderer, M.

Get full text

1665P Prognostic impact of diabetes and antidiabetic medication in pancreatic cancer patients by Friedrich, A., Berger, J.M., Berchtold, L., Wolf, P., Leutner, M., Prager, G., Preusser, M., Berghoff, A.S., Bergen, E.S.

Get full text

2109P Vitamin A, D and E levels in patients with solid tumors undergoing palliative systemic cancer treatment by Berger, J.M., Englisch, C., Gottmann, L., Korpan, M., Kleinberger, M., Starzer, A.M., Marculescu, R., Preusser, M., Berghoff, A.S.

Get full text

1400P Initial symptoms and their association with survival in patients with stage II-III gastroesophageal adenocarcinoma by Puhr, H.C., Krotka, P., Koenig, F., Berghoff, A.S., Preusser, M., Ilhan-Mutlu, A.

Get full text

1428P Circulating nutritional biomarkers and their association with survival in patients with metastatic gastroesophageal cancer by Puhr, H.C., Kuchling, D., Jahic, L., Takats, J., Berghoff, A.S., Preusser, M., Ilhan-Mutlu, A.

Get full text

2115P Pre-cachexia incidence in patients with solid cancer: A cross-sectional study by Gottmann, L., Berchtold, L., Mair, M., Starzer, A.M., Fürst, J.H., Berger, J.M., Englisch, C., Kleinberger, M., Korpan, M., Hütterer, E., Bergen, E.S., Preusser, M., Berghoff, A.S.

Get full text

537P S100A9 serum levels are associated with survival prognosis in patients with brain metastases by Steindl, A., Kienzle, A., Tomasich, E., Berger, J.M., Englisch, C., Gottmann, L., Korpan, M., Kleinberger, M., Starzer, A.M., Kiesel, B., Widhalm, G., Eckert, F., Preusser, M., Berghoff, A.S.

Get full text

1844MO Association of peripheral blood leukocyte DNA methylation profiles with the development of depressive symptoms in lung cancer patients undergoing systemic therapy by Starzer, A.M., Fuerst, J.H., Tomasich, E., Gottmann, L., Berger, J.M., Korpan, M., Englisch, C., Kleinberger, M., Moik, F., Heller, G., Carlberg, L., Preusser, M., Berghoff, A.S.

Get full text

509P Spatial analysis of tumor-associated macrophages within the tumor microenvironment of primary tumors and matched brain metastases by Kleinberger, M., Cifci, D., Paiato, C., Tomasich, E., Mair, M., Steindl, A., Carrero, Z., Berchtold, L., Hainfellner, J.A., Müllauer, L., Heller, G., Kather, J.N., Preusser, M., Berghoff, A.S.

Get full text

528P Progression risk after pregnancy in patients with glioma by Leibetseder, A., Mair, M., Aichholzer, M., Widhalm, G., Eckert, F., Wöhrer, A., Weis, S., Helbok, R., Preusser, M., Pichler, J., Berghoff, A.S.

Get full text

1774P Exploration of torque teno virus (TTV) levels as marker for immune suppression during systemic therapy in advanced solid cancer patients by Starzer, A.M., Mayer, J., Haselboeck, H., Kreminger, J., Berger, J., Moik, F., Goerzer, I., Preusser, M., Puchhammer, E., Berghoff, A.S.

Get full text

345MO Treatment associated changes in the inflammatory microenvironment composition of brain metastases by Steindl, A., Feldmann, K., Hatziioannou, T., Kleinberger, M., Dieckmann, K., Widhalm, G., Gatterbauer, B., Hainfellner, J.A., Preusser, M., Berghoff, A.S.

Get full text

363O Clinical characterization of a real-life cohort of 6001 patients with brain metastases from solid cancers treated between 1986-2020 by Steindl, A., Kreminger, J., Moor, E., Starzer, A., Dieckmann, K., Gatterbauer, B., Widhalm, G., Preusser, M., Berghoff, A.S.

Get full text

1462P Prognostic impact of clinical and laboratory nutritional markers in resectable gastroesophageal cancer by Puhr, H.C., Saliternig, L., Steindl, A., Paireder, M., Asari, R., Schoppmann, S.F., Berghoff, A.S., Preusser, M., Ilhan-Mutlu, A.

Get full text